Cargando…

Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

Detalles Bibliográficos
Autores principales:	Kirschner, Martin, Rolles, Benjamin, Crysandt, Martina, Röllig, Christoph, Stölzel, Friedrich, Kramer, Michael, Bornhäuser, Martin, Serve, Hubert, Platzbecker, Uwe, Müller-Tidow, Carsten, Kricheldorf, Kim, Vieri, Margherita, Begemann, Matthias, Maurer, Angela, Wlodarski, Marcin W., Sahoo, Sushree S., Brümmendorf, Tim H., Jost, Edgar, Beier, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561384/ https://www.ncbi.nlm.nih.gov/pubmed/36258922 http://dx.doi.org/10.1097/HS9.0000000000000787

Ejemplares similares

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia
por: Alakel, Nael, et al.
Publicado: (2017)

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
por: Eckardt, Jan-Niklas, et al.
Publicado: (2022)

Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
por: Eckardt, Jan-Niklas, et al.
Publicado: (2021)

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia
por: Kayser, Sabine, et al.
Publicado: (2023)

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia
por: Kunadt, Desiree, et al.
Publicado: (2020)

Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns
por: Božić, Tanja, et al.
Publicado: (2021)

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATION OF ACTIONABLE TARGETS FOR MOLECULAR-GUIDED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Stölzel, Friedrich, et al.
Publicado: (2023)

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
por: Kayser, Sabine, et al.
Publicado: (2022)

Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
por: Enßle, Julius C., et al.
Publicado: (2023)

Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial
por: Ruhnke, Leo, et al.
Publicado: (2023)

Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood
por: Michler, Pia, et al.
Publicado: (2021)

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia
por: Kunadt, Desiree, et al.
Publicado: (2020)

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms
por: Ruhnke, Leo, et al.
Publicado: (2021)

Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita
por: Vieri, Margherita, et al.
Publicado: (2020)

Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
por: Heidenreich, Falk, et al.
Publicado: (2023)

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia
por: Ruhnke, Leo, et al.
Publicado: (2021)

The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia
por: Vucinic, Vladan, et al.
Publicado: (2021)

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Bill, Marius, et al.
Publicado: (2023)

Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria
por: Tometten, Mareike, et al.
Publicado: (2023)

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
por: Eckardt, Jan-Niklas, et al.
Publicado: (2022)

A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia
por: Zhou, Fengbiao, et al.
Publicado: (2023)

DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
por: Božić, Tanja, et al.
Publicado: (2015)

Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation
por: Kunadt, Desiree, et al.
Publicado: (2022)

P804: EX VIVO TREATMENT WITH ELTROMBOPAG RESCUES HEMATOPOIETIC STEM CELLS FROM ANTI-THYMOCYTE GLOBULIN-RELATED DAMAGE DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANEMIA
por: Vieri, M., et al.
Publicado: (2022)

Deep sequencing in CD34(+) cells from peripheral blood enables sensitive detection of measurable residual disease in AML
por: Stasik, Sebastian, et al.
Publicado: (2022)

The Genomic Landscape of Myeloid Malignancies: Options for Pan-myeloid Therapies?
por: Heidel, Florian H., et al.
Publicado: (2021)

The prevalence of extramedullary acute myeloid leukemia detected by (18)FDG-PET/CT: final results from the prospective PETAML trial
por: Stölzel, Friedrich, et al.
Publicado: (2020)

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
por: Hess, Patrick P., et al.
Publicado: (2022)

Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia — A Randomised SAL Pilot Study
por: Krug, Utz, et al.
Publicado: (2012)

miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia
por: Vu, Thi Thanh, et al.
Publicado: (2020)

DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
por: Rolles, Benjamin, et al.
Publicado: (2023)

Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
por: Bütow, Marlena, et al.
Publicado: (2022)

Germline POT1 Variants Can Predispose to Myeloid and Lymphoid Neoplasms
por: Lim, Tristan L., et al.
Publicado: (2021)

GATA2 deficiency and related myeloid neoplasms
por: Wlodarski, Marcin W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pkic88avmjp3hh79vdqsh9a8tf